SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-013900
Filing Date
2019-04-30
Accepted
2019-04-29 21:05:39
Documents
4
Period of Report
2019-06-10
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A gnpx-def14a_20190610.htm DEF 14A 672854
2 GRAPHIC ge0ua15wjsi2000003.jpg GRAPHIC 35206
3 GRAPHIC ge0ua15wjsi2000002.jpg GRAPHIC 71064
4 GRAPHIC ge0ua15wjsi2000001.jpg GRAPHIC 4873
  Complete submission text file 0001564590-19-013900.txt   827431
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38244 | Film No.: 19777983
SIC: 2834 Pharmaceutical Preparations